View in EDS HTML Full Text PDF Full Text

Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index.

Saved in:
Bibliographic Details
Title: Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index.
Authors: O'Regan RM; Department of Medicine, University of Rochester, Rochester, New York., Ren Y; IBCSG Statistical Center, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts., Zhang Y; Biotheranostics, A Hologic Company, San Diego, California., Siuliukina N; Biotheranostics, A Hologic Company, San Diego, California., Schnabel CA; Biotheranostics, A Hologic Company, San Diego, California., Kammler R; International Breast Cancer Study Group, ETOP IBCSG Partners Foundation, Bern, Switzerland., Viale G; International Breast Cancer Study Group Central Pathology Office, IEO European Institute of Oncology IRCCS, Milan, Italy.; Department of Pathology and Laboratory Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy., Dell'Orto P; International Breast Cancer Study Group Central Pathology Office, IEO European Institute of Oncology IRCCS, Milan, Italy.; Department of Pathology and Laboratory Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy., Munzone E; Division of Medical Senology, IEO European Institute of Oncology IRCCS, Milan, Italy., Láng I; Clinexpert-Research, Budapest, Hungary., Tondini C; Ospedale Papa Giovanni XXIII, Bergamo, Italy., Gomez HL; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Chini C; Deaprment of Medical Oncology, Azienda Socio Sanitaria Territoriale dei Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy., Nicoletti SVL; Department of Medical Oncology, Ospedale Infermi Rimini, Ausl Romagna, Italy., Puglisi F; Department of Medicine, University of Udine, Udine, Italy.; Department of Medical Oncology, National Cancer Institute, Centro di Riferimento Oncologico, IRCCS, Aviano, Pordenone, Italy., Zaman K; Swiss Group for Clinical Cancer Research, Bern, Switzerland.; Department of Medical Oncology, Lausanne University Hospital, Lausanne, Switzerland., Goetz MP; Mayo Clinic Department of Oncology, and Alliance for Clinical Trials in Oncology, Rochester, Minnesota., Stearns V; Meyer Cancer Center, Weill Cornell Medicine, New York., Martino S; The Angeles Clinic and Research Institute, Santa Monica, California.; SWOG Cancer Research Network, San Antonio, Texas., Salim M; Allan Blair Cancer Center, Regina, Saskatchewan, Canada., Loibl S; German Breast Group Forschungs GmbH, Neu-Isenburg, Germany.; Goethe University, Frankfurt am Main, Germany., Geyer CE; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania.; NSABP Foundation, NRG Oncology, Pittsburgh, Pennsylvania., Bonnefoi HR; Institut Bergonié, Université de Bordeaux Collège Sciences de la santé, INSERM U1312, Bordeaux, France.; European Organization for Research and Treatment of Cancer, Brussels, Belgium., Ciruelos EM; Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain.; SOLTI Breast Cancer Research Cooperative Group, Barcelona, Spain., Loi S; International Breast Cancer Study Group, ETOP IBCSG Partners Foundation, Bern, Switzerland.; Division of Cancer Research, Peter MacCallum Cancer Center, Melbourne Australia.; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia., Colleoni M; International Breast Cancer Study Group, ETOP IBCSG Partners Foundation, Bern, Switzerland.; Division of Medical Senology, IEO European Institute of Oncology IRCCS, Milan, Italy., Fleming GF; The University of Chicago Medical Center, Chicago, Illinois., Francis PA; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Australia.; St Vincent's Hospital, Melbourne, Australia.; Breast Cancer Trials Australia and New Zealand, Newcastle, Australia., Walley BA; University of Calgary, Calgary, Alberta, Canada.; Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada., Pagani O; Geneva University Hospitals, Geneva, Switzerland.; Lugano University, Lugano, Switzerland.; Swiss Group for Clinical Cancer Research, Bern, Switzerland., Treuner K; Biotheranostics, A Hologic Company, San Diego, California., Regan MM; IBCSG Statistical Center, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Source: JAMA network open [JAMA Netw Open] 2025 Nov 03; Vol. 8 (11), pp. e2540931. Date of Electronic Publication: 2025 Nov 03.
Publication Type: Journal Article
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2574-3805
DOI:10.1001/jamanetworkopen.2025.40931